Patent details
EP3406610 Title: ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE, AND PREPARATION METHOD THEREOF
Basic Information
- Publication number:
- EP3406610
- PCT Application Number:
- CN2017071625
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP177410628
- PCT Publication Number:
- WO2017125031
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR COMPOSITE, AND PREPARATION METHOD THEREOF
- French Title of Invention:
- MÉTABOLITE ANTAGONISTE DU RÉCEPTEUR DE L'ANGIOTENSINE II ET COMPOSITE INHIBITEUR DE LA NEP, ET PROCÉDÉ DE PRÉPARATION ASSOCIÉ
- German Title of Invention:
- ANGIOTENSIN-II-REZEPTOR-ANTAGONISTMETABOLIT UND NEP-INHIBITORZUSAMMENSETZUNG SOWIE HERSTELLUNGSVERFAHREN DAFÜR
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 05/03/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 27/03/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 05/03/2025
- Unitary Effect Registration Date:
- 27/03/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 19/01/2017
- Grant date:
- 05/03/2025
- EP Publication Date:
- 28/11/2018
- PCT Publication Date:
- 27/07/2017
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/03/2025
- EP B1 Publication Date:
- 05/03/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 19/01/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/02/2025
- Name:
- Shenzhen Salubris Pharmaceuticals Co., Ltd
- Address:
- 37F Main Tower Lvjing Plaza, Che Gong Miao No. 6009 Shennan Road Futian District, Shenzhen, Guangdong 518040, China (CN)
Inventor
1
- Name:
- LI, Song
- Address:
- China (CN)
2
- Name:
- ZHI, Jianqiong
- Address:
- China (CN)
3
- Name:
- WANG, Yang
- Address:
- China (CN)
4
- Name:
- ZHENG, Yanxin
- Address:
- China (CN)
5
- Name:
- YAN, Jie
- Address:
- China (CN)
6
- Name:
- XU, Wenjie
- Address:
- China (CN)
Priority
1
- Priority Number:
- 201610038846
- Priority Date:
- 20/01/2016
- Priority Country:
- China (CN)
2
- Priority Number:
- 201610193099
- Priority Date:
- 30/03/2016
- Priority Country:
- China (CN)
3
- Priority Number:
- 201610430248
- Priority Date:
- 16/06/2016
- Priority Country:
- China (CN)
Classification
- IPC classification:
- A61K 31/41; A61K 31/216; A61P 9/00; C07D 403/10; C07C 233/47; C07C 231/12;
Publication
European Patent Bulletin
1
- Issue number:
- 202510
- Publication date:
- 05/03/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202515
- Publication date:
- 09/04/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202518
- Publication date:
- 30/04/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|